Podlesak Dennis

CIK 00013145955 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001314595

Recent Transactions

50 trades

Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2026-02-04+48,000→ 239,763 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2025-08-18$15.84/sh−19,200→ 191,763 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2025-08-18−19,200→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2025-08-18$7.20/sh+19,200→ 210,963 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2025-08-15$7.20/sh+19,200→ 210,963 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2025-08-15−4,800→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2025-08-15−14,400→ 0 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2025-08-15$15.54/sh−19,200→ 191,763 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2025-08-14−19,200→ 0 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2025-08-14$14.19/sh−19,200→ 191,763 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2025-08-14$7.20/sh+19,200→ 210,963 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2025-02-05+50,000→ 191,763 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2024-02-07+34,000→ 141,763 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-02-02+32,000→ 107,763 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-09-16$6.32/sh+5,419→ 81,182 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-09-16$23.43/sh−5,419→ 75,763 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-09-16$23.43/sh−6,556→ 75,763 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-09-16−5,419→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-09-16−6,556→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-09-16$6.35/sh+6,556→ 82,319 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-09-15$6.32/sh+66,840→ 142,603 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-09-15$24.20/sh−66,840→ 75,763 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-09-15−66,840→ 0 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-02-02+32,000→ 75,763 total
Other
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-10-05+463→ 43,763 total
Purchase
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-04-22$14.11/sh+13,967→ 43,300 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-02-03+29,333→ 29,333 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2020-02-12+44,000→ 44,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2019-06-10+44,000→ 44,000 total
Award
Adynxx, Inc.
Stock Option (Right to Buy)
2019-05-03+55,879→ 55,879 total
Award
Adynxx, Inc.
Stock Option (Right to Buy)
2019-05-03+396→ 396 total
Award
Adynxx, Inc.
Common Stock
2019-05-03+85,254→ 85,254 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2018-05-23+14,000→ 14,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2018-02-08+10,000→ 10,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2017-05-17+10,000→ 10,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2017-05-17+5,000→ 5,000 total
Disposition to Issuer
Tobira Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2016-11-01−1,071→ 0 total
Disposition to Issuer
Tobira Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2016-11-01−2,947→ 0 total
Disposition to Issuer
Tobira Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2016-11-01−17,695→ 0 total
Disposition to Issuer
Tobira Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2016-11-01−232→ 0 total
Disposition to Issuer
Tobira Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2016-11-01−27,500→ 0 total
Disposition to Issuer
Tobira Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2016-11-01−9,314→ 0 total
Disposition to Issuer
Tobira Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2016-11-01−232→ 0 total
Disposition to Issuer
Tobira Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2016-11-01−10,253→ 0 total
Disposition to Issuer
Tobira Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2016-11-01−40,733→ 0 total
Disposition to Issuer
Tobira Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2016-11-01−53,334→ 0 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2016-10-31+8,000→ 8,000 total
Award
Tobira Therapeutics, Inc.
Stock Options (right to buy)
2016-01-12+53,334→ 53,334 total
Award
Tobira Therapeutics, Inc.
Stock Options (right to buy)
2015-07-09+27,500→ 27,500 total
Award
Tobira Therapeutics, Inc.
Common Stock (right to buy)
2015-01-01+159,261→ 159,261 total

Companies

Recent Filings

Address

C/O SYNDAX PHARMACEUTICALS, INC. 730 THIRD AVENUE, FLOOR 9

NEW YORK, NY, 10017

View on SEC.gov